Spravato Treatment
Your Health, Our Commitment
SPRAVATO Treatment at GetWell Health System
Innovative Care for Treatment-Resistant Depression
At GetWell Health System, we are dedicated to offering innovative treatments that address complex mental health conditions. Our SPRAVATO treatment program is specifically designed for adults with treatment-resistant depression, providing a new hope where traditional therapies may have fallen short.
Understanding SPRAVATO
SPRAVATO (esketamine) nasal spray, in conjunction with an oral antidepressant, is approved for use in adults with treatment-resistant depression and depressive symptoms in adults with major depressive disorder (MDD) with acute suicidal ideation or behavior. SPRAVATO is a prescription medicine and is part of a class of medicines called NMDA receptor antagonists, which work differently than other antidepressants.
Treatment Process and Protocols
Administered Under Supervision
SPRAVATO is administered in a comfortable setting at GetWell Health System under the supervision of a healthcare provider. This ensures the safety and comfort of our patients during treatment.
Scheduled Treatment Sessions
Treatment consists of sessions that typically last about two hours. During this time, patients self-administer SPRAVATO under professional supervision and then remain under observation while the effects of the medication are monitored.
Comprehensive Support
In addition to the administration of SPRAVATO, our program includes comprehensive support services:
- Psychiatric Evaluation: To tailor treatment plans and ensure SPRAVATO is a suitable option.
- Counseling and Therapy: To complement the pharmacological treatment and support overall mental wellness.
- Follow-Up Care: Regular follow-ups to monitor progress and adjust treatment as needed.
Safety and Efficacy
The safety and efficacy of SPRAVATO have been established in multiple clinical trials. It has been shown to provide relief from the symptoms of depression quickly, often within hours or days, which is significantly faster than many traditional antidepressants.
Patient Eligibility
SPRAVATO treatment is specifically designed for patients diagnosed with treatment-resistant depression. Patients considering SPRAVATO must have tried other antidepressant treatments without adequate improvement.
Why Choose GetWell Health System for SPRAVATO Treatment?
- Expert Care Team: Our team specializes in mental health treatments and is trained in administering SPRAVATO safely and effectively.
- Patient-Centered Approach: We prioritize the comfort and specific needs of our patients, providing personalized care throughout the treatment journey.
- Commitment to Innovation: We embrace new and proven treatment modalities that can improve patient outcomes and enhance quality of life.
Contact Us to Explore Your Options
If you or a loved one is struggling with treatment-resistant depression, SPRAVATO treatment at GetWell Health System may offer the breakthrough you need. Contact us today to discuss your treatment options or to schedule a consultation. Our dedicated team is here to support you every step of the way toward a healthier, happier life.